An Indian American obstetrician and gynaecologist emphasized the importance of focusing on medical science and patient safety rather than political ideologies when it comes to abortion. Dr. Nisha Verma, testifying before the Senate Health, Education, Labour and Pensions Committee, highlighted the extensive research supporting the safety and effectiveness of medication abortion for over two decades. She stressed that restrictions influenced by politics are causing harm, with more than 7.5 million individuals in the US having used abortion drugs since their approval in 2000.
Verma, who practices in Massachusetts and Georgia, provides comprehensive reproductive healthcare, including contraception, miscarriage management, and abortion services. She underscored the complexity of abortion care but emphasized the importance of not distorting facts or undermining evidence-based medicine due to this complexity. Verma pointed out that many issues related to abortion stem from bans and restrictions, advocating that access to care enhances safety and well-being.
During the hearing, a brief tense moment arose when Republican Senator Josh Hawley questioned Verma about whether men can get pregnant. Verma redirected the focus back to medical evidence and care standards, highlighting the need to prioritize scientific facts over distractions. Committee chairman Sen. Bill Cassidy also engaged Verma on prescribing practices and gestational limits, with Verma emphasizing adherence to medical guidelines and individualized treatment decisions based on clinical judgment and specific circumstances.
Verma emphasized the importance of allowing patients to make informed decisions guided by medical professionals, families, and scientific evidence. She addressed concerns regarding coercion and misuse of abortion pills, condemning criminal acts while cautioning against using them as a basis for restricting legitimate care. Verma urged lawmakers to ensure that evidence-based care is readily accessible in local communities to support individuals in need.
The hearing, titled ‘Protecting Women: Exposing the Dangers of Chemical Abortion Drugs’, highlighted the debate between Republicans advocating for stricter federal controls on mifepristone and Democrats arguing against limiting abortion access nationwide. Mifepristone, approved by the US FDA for over two decades and also used in miscarriage care, was discussed as having an established medical role during the hearing.
